AI Verdict
NAGE has stronger fundamentals based on our AI analysis.
NAKAW vs NAGE Fundamental Comparison
| Metric | NAKAW | NAGE |
|---|---|---|
| Revenue | $1.8M | $129.4M |
| Net Income | $-52.2M | $17.4M |
| Net Margin | -2,867.6% | 13.4% |
| ROE | -10.2% | 22.7% |
| ROA | -7.1% | 16.3% |
| Current Ratio | 1.04x | 4.86x |
| Debt/Equity | 0.00x | 0.13x |
| EPS | $-0.26 | $0.20 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NAKAW vs NAGE: Frequently Asked Questions
Is NAKAW or NAGE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NAGE has stronger fundamentals. NAKAW is rated STRONG SELL (90% confidence) while NAGE is rated BUY (78% confidence). This is not investment advice.
How does NAKAW compare to NAGE fundamentally?
Nakamoto Inc. has ROE of -10.2% vs Niagen Bioscience, Inc.'s 22.7%. Net margins are -2,867.6% vs 13.4% respectively.
Which stock pays higher dividends, NAKAW or NAGE?
NAKAW has a dividend yield of N/A or no dividend while NAGE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NAKAW or NAGE for long term?
For long-term investing, consider that NAKAW has STRONG SELL rating with 90% confidence, while NAGE has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NAKAW vs NAGE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NAKAW vs NAGE, the AI consensus favors NAGE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.